h2o Therapeutics’ Apple Watch feature for Parkinson’s gets FDA medical device listing [Video]

Turkey-based digital health startup h2o therapeutics announced its new Apple Watch-enabled freezing of gait-cuing feature, dubbed Foggy, designed for Parkinson’s Disease patients has received FDA listing as a Class II medical device and is available via prescription.

According to the Parkinson’s Foundation, freezing of gait is a symptom of Parkinson’s Disease in which a patient experiences a temporary, involuntary inability to move. Freezing may also affect a person’s speech or other parts of the body. 

h2o therapeutics is a company that deploys augmented reality, AI and mobile-based digital therapeutics. The company also offers an early-detection COVID-19 smartwatch system named Covie.

Foggy utilizes the Taptic Engine in an Apple Watch to provide vibrotactile stimulation when a patient is experiencing freezing of gait. Users tap a complication that initiates feedback to assist with the condition. 

The feature is available through the company’s Parky app, which is accessible for Apple Watch users by prescription. 

“Cueing strategies hold immense promise in …